MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-11-08: Reporting owner Winslow Amy; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-11-08: Reporting owner ROLIH SUSAN; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-11-08: Reporting owner LUEKE MELISSA; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-11-08: Reporting owner Elagin Vecheslav A; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-11-08 | Winslow Amy Officer (EVP, Pres & CEO of Magellan) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.65 exercise price | 2017-11-13 | |
| 2017-11-08 | ROLIH SUSAN Officer (EVP, Global Reg & Quality Syst) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.65 exercise price | 2017-11-13 | |
| 2017-11-08 | LUEKE MELISSA Officer (Exec VP, CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.65 exercise price | 2017-11-13 | |
| 2017-11-08 | Elagin Vecheslav A Officer (EVP, R&D & Chf Scientific Off) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.65 exercise price | 2017-11-13 | |
| 2017-11-08 | EBERLY RICHARD Officer (EVP; Pres, Chief Comm Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.65 exercise price | 2017-11-13 | |
| 2017-11-08 | BALDINI LAWRENCE Officer (EVP, Pres Global Operations) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.65 exercise price | 2017-11-13 | |
| 2017-10-09 | Kenny John P. Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $14.50 exercise price | 2017-10-11 | |
| 2017-08-08 | Rice John McCune Jr. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $13.55 exercise price | 2017-08-09 | |
| 2017-05-19 | Elagin Vecheslav A Officer (EVP, R&D & Chf Scientific Off) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $13.60 exercise price | 2017-05-23 | |
| 2017-01-25 | PHILLIPS DAVID Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $12.80 exercise price | 2017-01-26 | |
| 2017-01-25 | Sazdanoff Catherine Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $12.80 exercise price | 2017-01-26 | |
| 2017-01-25 | McIlwraith John Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $12.80 exercise price | 2017-01-26 | |
| 2017-01-25 | Ellingwood Dwight E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $12.80 exercise price | 2017-01-26 | |
| 2017-01-25 | Anderson James M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $12.80 exercise price | 2017-01-26 |